Ursula von der Leyen, who today has just been re-elected as the president of the European Commission, has set out plans to introduce a Critical Medicines Act to secure Europe’s supply chain for essential medicines, in line with recent calls from generics and biosimilars industry association Medicines for Europe.
In her political guidelines for the next European Commission from 2024 to 2029, published today, von der Leyen underlined the need to “make our economy more resilient and less dependent
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?